345 related articles for article (PubMed ID: 35881777)
1. Antithrombotic therapy after transcatheter aortic valve implantation.
Greco A; Spagnolo M; Capodanno D
Expert Rev Med Devices; 2022 Jun; 19(6):499-513. PubMed ID: 35881777
[TBL] [Abstract][Full Text] [Related]
2. Antithrombotic pharmacotherapy after transcatheter aortic valve implantation: an update.
Greco A; Capranzano P; Barbanti M; Tamburino C; Capodanno D
Expert Rev Cardiovasc Ther; 2019 Jul; 17(7):479-496. PubMed ID: 31198065
[No Abstract] [Full Text] [Related]
3. Evolving concepts in the management of antithrombotic therapy in patients undergoing transcatheter aortic valve implantation.
van Ginkel DJ; Bor WL; Veenstra L; van 't Hof AWJ; Fabris E
Eur J Intern Med; 2022 Jul; 101():14-20. PubMed ID: 35623935
[TBL] [Abstract][Full Text] [Related]
4. What is the current optimal antithrombotic therapy after transcatheter aortic valve implantation? Current evidence from Japan and the world.
Kobari Y; Hayashida K;
J Cardiol; 2024 Mar; 83(3):141-148. PubMed ID: 37524301
[TBL] [Abstract][Full Text] [Related]
5. Management of antithrombotic therapy in patients undergoing transcatheter aortic valve implantation: a consensus document of the ESC Working Group on Thrombosis and the European Association of Percutaneous Cardiovascular Interventions (EAPCI), in collaboration with the ESC Council on Valvular Heart Disease.
Ten Berg J; Sibbing D; Rocca B; Van Belle E; Chevalier B; Collet JP; Dudek D; Gilard M; Gorog DA; Grapsa J; Grove EL; Lancellotti P; Petronio AS; Rubboli A; Torracca L; Vilahur G; Witkowski A; Mehilli J
Eur Heart J; 2021 Jun; 42(23):2265-2269. PubMed ID: 33822924
[TBL] [Abstract][Full Text] [Related]
6. Antithrombotic strategies after transcatheter aortic valve implantation: Insights from a network meta-analysis.
Kuno T; Takagi H; Sugiyama T; Ando T; Miyashita S; Valentin N; Shimada YJ; Kodaira M; Numasawa Y; Kanei Y; Hayashida K; Bangalore S
Catheter Cardiovasc Interv; 2020 Aug; 96(2):E177-E186. PubMed ID: 31609071
[TBL] [Abstract][Full Text] [Related]
7. Antithrombotic therapy in patients undergoing transcatheter aortic valve implantation.
Nijenhuis VJ; Brouwer J; Søndergaard L; Collet JP; Grove EL; Ten Berg JM
Heart; 2019 May; 105(10):742-748. PubMed ID: 30867148
[TBL] [Abstract][Full Text] [Related]
8. Post-Discharge Antithrombotic Therapy Following Transcatheter Aortic Valve Implantation in Australian Patients.
Sotade OT; Jorm LR; Kushwaha VV; Yu J; Sedrakyan A; Falster MO; Pearson SA
Heart Lung Circ; 2022 Aug; 31(8):1144-1152. PubMed ID: 35637093
[TBL] [Abstract][Full Text] [Related]
9. Rationale and design of Non-antithrombotic Therapy After Transcatheter Aortic Valve Implantation (NAPT) Trial.
Inohara T; Otsuka T; Watanabe Y; Shirai S; Tada N; Yamanaka F; Ueno H; Ohno Y; Tabata M; Suzuyama H; Asami M; Yamawaki M; Izumo M; Yamasaki K; Nishina H; Fuku Y; Mizutani K; Yashima F; Yamamoto M; Hayashida K
Contemp Clin Trials; 2023 Nov; 134():107358. PubMed ID: 37852534
[TBL] [Abstract][Full Text] [Related]
10. Antithrombotic treatment in patients undergoing transcatheter aortic valve implantation (TAVI).
Nijenhuis VJ; Bennaghmouch N; van Kuijk JP; Capodanno D; ten Berg JM
Thromb Haemost; 2015 Apr; 113(4):674-85. PubMed ID: 25653053
[TBL] [Abstract][Full Text] [Related]
11. Subclinical valve thrombosis in transcatheter aortic valve implantation: A systematic review and meta-analysis.
Woldendorp K; Doyle MP; Black D; Ng M; Keech A; Grieve SM; Bannon PG
J Thorac Cardiovasc Surg; 2021 Nov; 162(5):1491-1499.e2. PubMed ID: 32217021
[TBL] [Abstract][Full Text] [Related]
12. [Antithrombotic therapy in patients undergoing transcatheter aortic valve implantation].
Gargiulo G; Valgimigli M
G Ital Cardiol (Rome); 2016 Jun; 17(6 Suppl 2):4S-10. PubMed ID: 27384599
[TBL] [Abstract][Full Text] [Related]
13. Novel Perspective for Antithrombotic Therapy in TAVI.
Drakopoulou M; Soulaidopoulos S; Oikonomou G; Stathogiannis K; Latsios G; Synetos A; Tousoulis D; Toutouzas K
Curr Pharm Des; 2020; 26(23):2789-2803. PubMed ID: 32282297
[TBL] [Abstract][Full Text] [Related]
14. The search for optimal antithrombotic therapy in transcatheter aortic valve implantation: facts and uncertainties.
Ten Berg J; Rocca B; Angiolillo DJ; Hayashida K
Eur Heart J; 2022 Nov; 43(44):4616-4634. PubMed ID: 36130256
[TBL] [Abstract][Full Text] [Related]
15. Antithrombotic Therapy After Transcatheter Aortic Valve Replacement.
Capodanno D; Collet JP; Dangas G; Montalescot G; Ten Berg JM; Windecker S; Angiolillo DJ
JACC Cardiovasc Interv; 2021 Aug; 14(15):1688-1703. PubMed ID: 34353601
[TBL] [Abstract][Full Text] [Related]
16. Antithrombotic strategies after transcatheter aortic valve implantation: A systematic review and network meta-analysis of randomized controlled trials.
Ke Y; Wang J; Wang W; Guo S; Dai M; Wu L; Bao Y; Li B; Ju J; Xu H; Jin Y
Int J Cardiol; 2022 Sep; 362():139-146. PubMed ID: 35654173
[TBL] [Abstract][Full Text] [Related]
17. Antithrombotic Therapy for Transcatheter Valvular Interventions: A Revisit.
Mohammed S; El-Menyar A; Al-Janubi H; Shabana A; Alanazi Z
Curr Vasc Pharmacol; 2018 Jan; 16(2):107-113. PubMed ID: 28393705
[TBL] [Abstract][Full Text] [Related]
18. Updated clinical indications for transcatheter aortic valve implantation in patients with severe aortic stenosis: expert opinion of the Italian Society of Cardiology and GISE.
Indolfi C; Bartorelli AL; Berti S; Golino P; Esposito G; Musumeci G; Petronio S; Tamburino C; Tarantini G; Ussia G; Vassanelli C; Spaccarotella C; Violini R; Mercuro G; Romeo F
J Cardiovasc Med (Hagerstown); 2018 May; 19(5):197-210. PubMed ID: 29578921
[TBL] [Abstract][Full Text] [Related]
19. Antithrombotic Management for Transcatheter Aortic Valve Implantation.
Ya'Qoub L; Arnautovic J; Sharkawi M; AlAasnag M; Jneid H; Elgendy IY
J Clin Med; 2023 Dec; 12(24):. PubMed ID: 38137701
[TBL] [Abstract][Full Text] [Related]
20. Anticoagulation after Transcatheter Aortic Valve Implantation: Current Status.
Greco A; Capodanno D
Interv Cardiol; 2020 Apr; 15():e02. PubMed ID: 32382318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
